These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26287605)

  • 1. Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.
    Mochizuki D; Adams A; Warner KA; Zhang Z; Pearson AT; Misawa K; McLean SA; Wolf GT; Nör JE
    Oncotarget; 2015 Sep; 6(26):22822-35. PubMed ID: 26287605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
    Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y
    Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
    Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
    Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.
    Alraouji NN; Al-Mohanna FH; Ghebeh H; Arafah M; Almeer R; Al-Tweigeri T; Aboussekhra A
    Mol Carcinog; 2020 Sep; 59(9):1041-1051. PubMed ID: 32537818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma.
    Yun MR; Choi HM; Kang HN; Lee Y; Joo HS; Kim DH; Kim HR; Hong MH; Yoon SO; Cho BC
    Oncogene; 2018 Jan; 37(3):377-388. PubMed ID: 28945228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas.
    Adams A; Warner K; Pearson AT; Zhang Z; Kim HS; Mochizuki D; Basura G; Helman J; Mantesso A; Castilho RM; Wicha MS; Nör JE
    Oncotarget; 2015 Sep; 6(29):26633-50. PubMed ID: 26449187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2-p53 Interaction in Mucoepidermoid Carcinoma.
    Andrews A; Warner K; Rodriguez-Ramirez C; Pearson AT; Nör F; Zhang Z; Kerk S; Kulkarni A; Helman JI; Brenner JC; Wicha MS; Wang S; Nör JE
    Clin Cancer Res; 2019 Mar; 25(5):1588-1600. PubMed ID: 30498096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells.
    Zhang R; Chen X; Fu S; Xu L; Lin J
    Oncol Rep; 2020 Sep; 44(3):1224-1232. PubMed ID: 32705214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
    Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
    Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Protein Phosphatase 2A Sensitizes Mucoepidermoid Carcinoma to Chemotherapy via the PI3K-AKT Pathway in Response to Insulin Stimulus.
    Liu L; Wang H; Cui J; Zhang Q; Zhang W; Xu W; Lu H; Liu S; Shen S; Fang F; Li L; Yang W; Zhuang Z; Li J
    Cell Physiol Biochem; 2018; 50(1):317-331. PubMed ID: 30282066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells.
    Nakano T; Warner KA; Oklejas AE; Zhang Z; Rodriguez-Ramirez C; Shuman AG; Nör JE
    J Dent Res; 2021 Apr; 100(4):377-386. PubMed ID: 33073679
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Nazari F; Oklejas AE; Nör JE; Pearson AT; Jackson TL
    Cancer Res; 2020 Apr; 80(7):1451-1460. PubMed ID: 32041834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
    Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of salivary gland cancer stem cells requires mTOR signaling.
    Andrade NP; Warner KA; Zhang Z; Pearson AT; Mantesso A; Guimaraēs DM; Altemani A; Mariano FV; Nunes FD; Nör JE
    Cell Death Dis; 2021 Jan; 12(1):108. PubMed ID: 33479203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer.
    Goumas FA; Holmer R; Egberts JH; Gontarewicz A; Heneweer C; Geisen U; Hauser C; Mende MM; Legler K; Röcken C; Becker T; Waetzig GH; Rose-John S; Kalthoff H
    Int J Cancer; 2015 Sep; 137(5):1035-46. PubMed ID: 25604508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.
    Abubaker K; Luwor RB; Zhu H; McNally O; Quinn MA; Burns CJ; Thompson EW; Findlay JK; Ahmed N
    BMC Cancer; 2014 May; 14():317. PubMed ID: 24886434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma.
    Goto H; Kudo E; Kariya R; Taura M; Katano H; Okada S
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):465-74. PubMed ID: 25304617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3).
    Kandala PK; Srivastava SK
    BMC Med; 2012 Jan; 10():9. PubMed ID: 22280969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.
    Chen Z; Chen J; Gu Y; Hu C; Li JL; Lin S; Shen H; Cao C; Gao R; Li J; Ha PK; Kaye FJ; Griffin JD; Wu L
    Oncogene; 2014 Jul; 33(29):3869-77. PubMed ID: 23975434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma.
    Ni W; Chen Z; Zhou X; Yang R; Yu M; Lu J; Kaye FJ; Wu L
    Signal Transduct Target Ther; 2021 Jan; 6(1):27. PubMed ID: 33473104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.